Tokyo, Aug. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058765) titled 'Study of the relationships between breast milk composition, maternal and child health, and maternal genetic diversity' on Aug. 20.
Study Type:
Observational
Primary Sponsor:
Institute - Meiji Holdings Co., Ltd.
Condition:
Condition - Healthy mothers and their children
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - We will conduct genetic analysis using maternal saliva samples to explore genetic variants associated with breast milk composition, maternal health status, and the growth, development, health, and gut microbiota of the child.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Healthy mothers and their children participating in the MiNDS Study (Registration ID: UMIN000050032)
2) Mothers who, as research participants and guardians of their children, have given an explanation in Japanese about the purpose and contents of this research, fully understood it, volunteered, and agreed to participate.
Key exclusion criteria - 1) Mothers and their children who did not provide breast milk samples in the MiNDS Study
2) Mothers and their children who did not complete the background questionnaire in the MiNDS Study
Target Size - 500
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 06 Month 16 Day
Date of IRB - 2025 Year 06 Month 26 Day
Anticipated trial start date - 2025 Year 08 Month 20 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067193
Disclaimer: Curated by HT Syndication.
